MYCN and neuroblastoma: Within the International Neuroblastoma Risk Group (INRG) classification system [6], it is evaluated in the INRG staging system [7], along with other statistically significant prognostic factors, including age, histologic category, grade of tumor differentiation, ploidy, MYCN amplification, and 11q aberration.